Maximus vs Willow: Which GLP-1 Provider Is Better?

By Iacob Pastina, Independent Researcher

48 providers verified independently·Independent research·How we rank →

Willow beats Maximus overall, scoring 8.2/10 vs 7.1/10. Willow is more affordable at $299/mo vs $300/mo. Choose Maximus for men who want glp-1 alongside testosterone or other men's hea. Choose Willow for users who want comprehensive clinical support with flexibili.

A side-by-side comparison of Maximus and Willow covering pricing, scores, medication types, insurance, and more to help you decide.

Maximus

#46 of 48

7.1/10

Men's performance and health platform offering GLP-1 alongside testosterone optimization and other protocols.

Visit Maximus

Higher Rated

Willow

#8 of 48

8.2/10

Personalized GLP-1 weight loss with ongoing clinical support. Compounded semaglutide and tirzepatide only — Willow explicitly does not prescribe brand-name Wegovy or Zepbound. Added oral compounded semaglutide tablets as a non-injectable option.

Visit Willow

Feature	Maximus	Willow
Our Score	7.1/10	8.2/10
Starting Price	$300/mo	$299/mo
Medication Type	Compounded	Compounded
Insurance Accepted	No	No
Best For	Men who want GLP-1 alongside testosterone or other men's health protocols	Users who want comprehensive clinical support with flexibility between injectable and oral compounded semaglutide routes
Ranking	#46	#8

Pros & Cons Compared

Maximus

Pros

+Lowest entry price in the market — $79.99/mo microdose semaglutide, $99.99/mo 3-month starter pack
+GLP-1 microdosing available for BMI as low as 22 — the only platform serving patients below standard obesity criteria
+Nausea-reducing formula with added glycine and B12 to ease GLP-1 side effects
+Free expedited shipping on all medication orders

Cons

−Deceptive pricing structure — $99.99/mo is intro only, standard dosing is $299.99/mo with separate $28-35 consultation fees and $199-349/yr lab costs
−Refuses to disclose compounding pharmacy partners — a transparency red flag for a healthcare platform
−Prices increase as dose escalates on bulk plans — unpredictable total cost over time

Willow

Pros

+Includes monthly provider check-ins and dose adjustments at no extra cost
+Offers both injectable AND oral compounded semaglutide — one of few platforms with a daily oral tablet option
+$299/mo all-in for compounded semaglutide with monthly provider support
+90%+ patient retention rate after 3 months per their published outcomes data

Cons

−Compounded-only — no brand-name Wegovy or Zepbound through the platform
−Tirzepatide pricing reaches $499-$524 at higher doses — starting dose is $399/mo
−Cash-pay only — no insurance billing, though they provide superbills for FSA/HSA
−Founded in 2024 — less track record than Ro or Hims, though growth has been fast

Our Verdict

Willow edges out Maximus with a score of 8.2/10 vs 7.1/10. If budget is your priority, Willow starts at $299/mo compared to Maximus's $300/mo. Choose Maximus if you want: men who want glp-1 alongside testosterone or other men's health protocols. Choose Willow if you want: users who want comprehensive clinical support with flexibility between injectable and oral compounded semaglutide routes.

Still undecided? Editor's #1 Overall Pick

Eden Health GLP-1

$249/mo · 8.9/10 · Both

If neither Maximus nor Willow feels like the right fit, our overall #1 pick across all 48 GLP-1 telehealth providers is Eden Health GLP-1 — strongest balance of clinical oversight, transparent pricing, and verified availability.

Visit Eden Health GLP-1→Read our full Eden Health GLP-1 review